RIRichard T Ellison Iii

Richard T Ellison Iii

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Richard T Ellison Iii has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Machine Learning–Enhanced Surveillance for Surgical Site Infections in Patients Undergoing Colon Surgery: Model Development and Evaluation Study

    by Ugur Celik, Feifan Liu, Kimiyoshi Kobayashi, Richard T Ellison Iii, Yurima Guilarte-Walker, Deborah Ann Mack, Qiming Shi, Adrian Zai

    Background: Surgical site infections (SSIs) are one of the most common health care–associated infections, accounting for nearly 20% of all health care–associated infections in hospitalized patients. SSIs are associated with longer hospital stays, increased readmission rates, higher health care costs, and a mortality rate twice that of patients without infections. Objective: This study aimed to develop and evaluate machine learning (ML) models for augmenting SSI surveillance after colon surgery with the goal of improving the efficiency of infection control practices by prioritizing patients at high risk. Methods: We conducted a retrospective study using data from 1508 patients undergoing colon surgery treated between 2018 and 2023 at a single academic medical center. Of these 1508 patients, 66 (4.4%) developed SSIs as adjudicated by infection control practitioners following Centers for Disease Control and Prevention National Healthcare Safety Network criteria. Data included 78 structured variables (eg, demographics, comorbidities, vital signs, laboratory tests, medications, and operative details) and 2 features derived from unstructured clinical notes using natural language processing. ML models―logistic regression, random forest, and Extreme Gradient Boosting (XGBoost)―were trained using stratified 80/20 train-test splits. Class imbalance was addressed using cost-sensitive learning and the synthetic minority oversampling technique. Model performance was evaluated using precision, recall, F1-score, area under the receiver operating characteristic curve, and Brier scores for calibration. Results: Of the 1508 patients, those who developed SSIs had longer hospital stays (mean 8.1, SD 6.8 days vs mean 6.3, SD 10.5 days; P<.001), higher rates of an American Society of Anesthesiologists score of 3 (52/66, 79% vs 653/1442, 45.3%; P<.001), and elevated white blood cell counts (51/66, 77% vs 734/1442, 50.9%; P<.001). XGBoost achieved the best overall performance with an area under the receiver operating characteristic curve of 0.788, precision of 50%, recall of 38%, and Brier score of 0.035. Random forest yielded perfect precision (100%) but lower recall (23%), with a Brier score of 0.034. Logistic regression showed the highest recall (46%) but the lowest precision (10%), with a Brier score of 0.139. Feature importance analysis using Shapley additive explanations (SHAP) values revealed that the top predictors included recovery duration (SHAP=1.18), SSI keyword frequency (SHAP=1.12), patient age (SHAP=1.12), and American Society of Anesthesiologists score (SHAP=0.94), with natural language processing–derived features ranking among the top 10. Conclusions: ML models can augment traditional SSI surveillance by improving early identification of patients at high risk. The XGBoost model offered the best trade-off between discrimination and calibration, suggesting its utility in clinical workflows. Incorporating structured and unstructured electronic health record data enhances model accuracy and clinical relevance, supporting scalable and efficient infection control practices.


  • Open Access

    Machine Learning–Enhanced Surveillance for Surgical Site Infections in Patients Undergoing Colon Surgery: Model Development and Evaluation Study (Preprint)

    by Ugur Celik, Feifan Liu, Kimiyoshi Kobayashi, Richard T Ellison Iii, Yurima Guilarte-Walker, Deborah Ann Mack, Qiming Shi, Adrian Zai

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Surgical site infections (SSIs) are one of the most common health care–associated infections, accounting for nearly 20% of all health care–associated infections in hospitalized patients. SSIs are associated with longer hospital stays, increased readmission rates, higher health care costs, and a mortality rate twice that of patients without infections. Objective: This study aimed to develop and evaluate machine learning (ML) models for augmenting SSI surveillance after colon surgery with the goal of improving the efficiency of infection control practices by prioritizing patients at high risk. Methods: We conducted a retrospective study using data from 1508 patients undergoing colon surgery treated between 2018 and 2023 at a single academic medical center. Of these 1508 patients, 66 (4.4%) developed SSIs as adjudicated by infection control practitioners following Centers for Disease Control and Prevention National Healthcare Safety Network criteria. Data included 78 structured variables (eg, demographics, comorbidities, vital signs, laboratory tests, medications, and operative details) and 2 features derived from unstructured clinical notes using natural language processing. ML models―logistic regression, random forest, and Extreme Gradient Boosting (XGBoost)―were trained using stratified 80/20 train-test splits. Class imbalance was addressed using cost-sensitive learning and the synthetic minority oversampling technique. Model performance was evaluated using precision, recall, F1-score, area under the receiver operating characteristic curve, and Brier scores for calibration. Results: Of the 1508 patients, those who developed SSIs had longer hospital stays (mean 8.1, SD 6.8 days vs mean 6.3, SD 10.5 days; P<.001), higher rates of an American Society of Anesthesiologists score of 3 (52/66, 79% vs 653/1442, 45.3%; P<.001), and elevated white blood cell counts (51/66, 77% vs 734/1442, 50.9%; P<.001). XGBoost achieved the best overall performance with an area under the receiver operating characteristic curve of 0.788, precision of 50%, recall of 38%, and Brier score of 0.035. Random forest yielded perfect precision (100%) but lower recall (23%), with a Brier score of 0.034. Logistic regression showed the highest recall (46%) but the lowest precision (10%), with a Brier score of 0.139. Feature importance analysis using Shapley additive explanations (SHAP) values revealed that the top predictors included recovery duration (SHAP=1.18), SSI keyword frequency (SHAP=1.12), patient age (SHAP=1.12), and American Society of Anesthesiologists score (SHAP=0.94), with natural language processing–derived features ranking among the top 10. Conclusions: ML models can augment traditional SSI surveillance by improving early identification of patients at high risk. The XGBoost model offered the best trade-off between discrimination and calibration, suggesting its utility in clinical workflows. Incorporating structured and unstructured electronic health record data enhances model accuracy and clinical relevance, supporting scalable and efficient infection control practices.

  • Open Access

    Prospective Trial of a Passive Diversion Device to Reduce Blood Culture Contamination

    by Sami Arnaout, Shannon Stock, Julia M Clifford, Thomas C Greenough, Azalea Wedig, Michael J Mitchell, Richard T Ellison

    Background: Blood culture contaminants can lead to inappropriate antibiotic use, prolonged length of stay, and additional hospital costs. Several devices have been developed to reduce the risk of blood culture contamination by diverting a portion of the initial blood sample from the blood culture bottle. We assessed the effectiveness of 1 blood diversion device (BDD) in a prospective trial performed at the 2 separate emergency departments (EDs) of an academic medical center. Methods: A multiphase prospective crossover trial was performed with the BDD in use at 1 ED and standard equipment at the other ED for 10 weeks, and a second 10-week study phase was conducted with the use of the BDD and standard equipment in the EDs reversed. Contaminants were identified both by standard clinical microbiology lab criteria and by independent retrospective review by 3 infectious disease (ID) physicians. The primary analysis was performed based on intention-to-use data using the physician review of positive blood cultures. Results: A total of 5637 blood samples were obtained, with 5625 samples analyzed after 12 blood culture results were deemed inconclusive by the ID physician review. The University ED had a higher blood culture contamination rate of 2.9% compared with the Memorial ED at 1.4%. In an intention-to-use analysis, the overall contamination rates were 2.0% and 2.9% in the BDD and standard equipment periods, respectively (P = .03), and in an actual-use analysis the contamination rates were 1.2% and 3.0% for the BDD and standard equipment, respectively (P < .001). Conclusions: The BDD was associated with significantly lower blood culture contamination rates at the institution's 2 EDs, with a stronger effect noted at the campus caring for higher acuity patients.


  • Open Access

    COVID-19 Variant Surveillance and Social Determinants in Central Massachusetts: Development Study

    by Qiming Shi, Carly Herbert, Doyle V Ward, Karl Simin, Beth A McCormick, Richard T Ellison Iii, Adrian H Zai

    Background: Public health scientists have used spatial tools such as web-based Geographical Information System (GIS) applications to monitor and forecast the progression of the COVID-19 pandemic and track the impact of their interventions. The ability to track SARS-CoV-2 variants and incorporate the social determinants of health with street-level granularity can facilitate the identification of local outbreaks, highlight variant-specific geospatial epidemiology, and inform effective interventions. We developed a novel dashboard, the University of Massachusetts’ Graphical user interface for Geographic Information (MAGGI) variant tracking system that combines GIS, health-associated sociodemographic data, and viral genomic data to visualize the spatiotemporal incidence of SARS-CoV-2 variants with street-level resolution while safeguarding protected health information. The specificity and richness of the dashboard enhance the local understanding of variant introductions and transmissions so that appropriate public health strategies can be devised and evaluated. Objective: We developed a web-based dashboard that simultaneously visualizes the geographic distribution of SARS-CoV-2 variants in Central Massachusetts, the social determinants of health, and vaccination data to support public health efforts to locally mitigate the impact of the COVID-19 pandemic. Methods: MAGGI uses a server-client model–based system, enabling users to access data and visualizations via an encrypted web browser, thus securing patient health information. We integrated data from electronic medical records, SARS-CoV-2 genomic analysis, and public health resources. We developed the following functionalities into MAGGI: spatial and temporal selection capability by zip codes of interest, the detection of variant clusters, and a tool to display variant distribution by the social determinants of health. MAGGI was built on the Environmental Systems Research Institute ecosystem and is readily adaptable to monitor other infectious diseases and their variants in real-time. Results: We created a geo-referenced database and added sociodemographic and viral genomic data to the ArcGIS dashboard that interactively displays Central Massachusetts’ spatiotemporal variants distribution. Genomic epidemiologists and public health officials use MAGGI to show the occurrence of SARS-CoV-2 genomic variants at high geographic resolution and refine the display by selecting a combination of data features such as variant subtype, subject zip codes, or date of COVID-19–positive sample collection. Furthermore, they use it to scale time and space to visualize association patterns between socioeconomics, social vulnerability based on the Centers for Disease Control and Prevention’s social vulnerability index, and vaccination rates. We launched the system at the University of Massachusetts Chan Medical School to support internal research projects starting in March 2021. Conclusions: We developed a COVID-19 variant surveillance dashboard to advance our geospatial technologies to study SARS-CoV-2 variants transmission dynamics. This real-time, GIS-based tool exemplifies how spatial informatics can support public health officials, genomics epidemiologists, infectious disease specialists, and other researchers to track and study the spread patterns of SARS-CoV-2 variants in our communities.


  • Open Access

    COVID-19 Variant Surveillance and Social Determinants in Central Massachusetts: Development Study (Preprint)

    by Qiming Shi, Carly Herbert, Doyle V Ward, Karl Simin, Beth A McCormick, Richard T Ellison Iii, Adrian H Zai

    BACKGROUND Public health scientists have used spatial tools such as web-based Geographical Information System (GIS) applications to monitor and forecast the progression of the COVID-19 pandemic and track the impact of their interventions. The ability to track SARS-CoV-2 variants and incorporate the social determinants of health with street-level granularity can facilitate the identification of local outbreaks, highlight variant-specific geospatial epidemiology, and inform effective interventions. We developed a novel dashboard, the University of Massachusetts’ Graphical user interface for Geographic Information (MAGGI) variant tracking system that combines GIS, health-associated sociodemographic data, and viral genomic data to visualize the spatiotemporal incidence of SARS-CoV-2 variants with street-level resolution while safeguarding protected health information. The specificity and richness of the dashboard enhance the local understanding of variant introductions and transmissions so that appropriate public health strategies can be devised and evaluated. OBJECTIVE We developed a web-based dashboard that simultaneously visualizes the geographic distribution of SARS-CoV-2 variants in Central Massachusetts, the social determinants of health, and vaccination data to support public health efforts to locally mitigate the impact of the COVID-19 pandemic. METHODS MAGGI uses a server-client model–based system, enabling users to access data and visualizations via an encrypted web browser, thus securing patient health information. We integrated data from electronic medical records, SARS-CoV-2 genomic analysis, and public health resources. We developed the following functionalities into MAGGI: spatial and temporal selection capability by zip codes of interest, the detection of variant clusters, and a tool to display variant distribution by the social determinants of health. MAGGI was built on the Environmental Systems Research Institute ecosystem and is readily adaptable to monitor other infectious diseases and their variants in real-time. RESULTS We created a geo-referenced database and added sociodemographic and viral genomic data to the ArcGIS dashboard that interactively displays Central Massachusetts’ spatiotemporal variants distribution. Genomic epidemiologists and public health officials use MAGGI to show the occurrence of SARS-CoV-2 genomic variants at high geographic resolution and refine the display by selecting a combination of data features such as variant subtype, subject zip codes, or date of COVID-19–positive sample collection. Furthermore, they use it to scale time and space to visualize association patterns between socioeconomics, social vulnerability based on the Centers for Disease Control and Prevention’s social vulnerability index, and vaccination rates. We launched the system at the University of Massachusetts Chan Medical School to support internal research projects starting in March 2021. CONCLUSIONS We developed a COVID-19 variant surveillance dashboard to advance our geospatial technologies to study SARS-CoV-2 variants transmission dynamics. This real-time, GIS-based tool exemplifies how spatial informatics can support public health officials, genomics epidemiologists, infectious disease specialists, and other researchers to track and study the spread patterns of SARS-CoV-2 variants in our communities.

  • Open Access

    RE: Preventability of hospital onset bacterermia and fungemia: A pilot study of potential healthcare-associated infection outcome measure, by Dantes et al (2019)

    by Anna M. Civitarese, Eric Ruggieri, J. Mattias Walz, Deborah Ann Mack, Stephen O. Heard, Michael Mitchell, Craig M. Lilly, Karen E. Landry, Richard T. Ellison

    Du contrôle sanitaire des eaux destinées à la consommation humaine.